Arantxa Sancho, director of the Department of Medical-Scientific Affairs at Farmaindustria, participates in the informative seminar on pharmacogenomic biomarkers organised by the Aemps. Farmaindustria.es On 29 […]

The Farma-Biotech programme facilitates the efficient exchange of information and personal knowledge between research groups, small spin-off companies and the pharmaceutical industry. Since its inception in […]

Farmaindustria is leading a project to bring clinical trials to primary care to help decentralise this strategy. laopiniondezamora.es ‘Transforming primary care through clinical trials’ was the […]

Assessing Europe’s clinical trial ecosystem, produced by Iqvia for Efpia and Vaccines Europe, shows a 22-12% drop in the share of studies on the continent over […]

The Extraordinary General Assembly on Thursday unanimously elected the CEO of Amgen Iberia to lead the Association for the next two years. Source: Farmaindustria.es Fina Lladós […]

There are currently more than 600 clinical trials underway for children and adolescents in Spain, almost half of them focused on rare diseases. The Spanish Network […]

The closing table of the 5th Symposium of the Healthcare Observatory reviewed the challenges facing the sector. Spain, as a leader of a European health policy’. […]

The Clinical Trials Information System (CTIS), managed by the European Medicines Agency (EMA), is a single entry point for the submission and assessment of clinical trial […]

From R&D to pharmacovigilance to production and incremental innovation, the industry is constantly seeking to maximise risk reduction in medicines. On World Patient Safety Day, WHO […]

Artificial intelligence applied to medical research, top technology trend in 2024 according to the World Economic Forum.   Farmaindustria.es Artificial intelligence (AI) is a true revolution […]

The report highlights the sector’s contribution to the EU’s R&D and trade balance and recognises the worrying trend of Europe losing ground to other regions of […]

The Director General of Farmaindustria, Juan Yermo, presents the sector’s potential and challenges on the second day of the 23rd Annual Meeting of the Pharmaceutical Industry […]